Research Desk
Pulling the memo together.
Fetching live price, fundamentals, analyst consensus, and news.
Fetching live price, fundamentals, analyst consensus, and news.
Accumulate rating, composite score 7/10 at $402.29 (+8.47 (+2.15%)). Full scorecard, fundamentals, technicals, sentiment, risks, and catalysts below — or look up a different ticker.
| Dimension | Score | Key Signal |
|---|---|---|
| Fundamentals | 8/10 | healthy revenue growth (+18% YoY); excellent margins (39.3%) |
| Technicals | 5/10 | below 200-day |
| Sentiment / News | 8/10 | 63 of 68 analysts bullish — strong consensus buy |
| Composite | 7/10 | Rating: Accumulate |
Microsoft Corp (Technology) trades at $402.29 with a market capitalization of $2.99T.
Revenue grew +17.9% year-over-year on a trailing basis. Trailing net profit margin sits at 39.3%. At a trailing P/E of 23.3, the market is pricing in moderate growth expectations. The balance sheet carries a debt-to-equity ratio of 0.26 — a notably clean capital structure.
The 52-week range spans $349.20 to $555.45. Current price sits -27.6% from the high and +15% from the low — well below its recent peak.
The moving-average structure is mixed (50-day $401.28, 200-day $438.77). No clean trend signal here; the tape is in transition. The 14-day RSI at 56.1 is in neutral territory. MACD histogram is positive at +3.48, confirming bullish short-term momentum.
Performance: 30-day return -6.0%, 90-day -0.9%, 1-year -21.4%. Maximum drawdown over the trailing year reached -34.9%. Annualized volatility sits at 27.7% — moderate, in line with broad market averages.
As of 2026-07-01, 68 analysts cover MSFT: 23 Strong Buy, 40 Buy, 5 Hold, 0 Sell, 0 Strong Sell. The consensus skew is decisively bullish. Notably, bullish coverage has expanded versus the prior month.
The most recent earnings (2026-03-31) beat expectations: actual EPS of $4.27 versus consensus of $4.14 (+0.13 surprise). A 3.1% positive surprise.
The composite rating of Accumulate (7/10) reflects strength across fundamentals and analyst sentiment. Thesis breaks if analyst revisions turn sharply negative or earnings execution falters.